TOC dettagliato di approfondimenti sul mercato della diagnostica delle malattie rare globali, previsto a 020322
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Disease Diagnostics Market Size Growth Rate by Type, 2018 VS 2024 VS 020322
1.2.2 Hematology
1.2.3 Oncology
1.3 Market by Application
1.3.1 Global Rare Disease Diagnostics Market Size Growth Rate by Application, 2018 vs 2024 vs 020322
1.3.2 Laboratori ospedalieri
1.3.3 Laboratori diagnostici
1.3.4 Laboratori di test genetici
1.3.5 Laboratori di ricerca sul cancro
1.3.6 Altri
1.4 Assunzioni e limiti
1.5 Evitazioni di studio <1.6 anni <1.1.6 Tendenze
2.1 Prospettiva del mercato della diagnostica delle malattie rare globali (2018-020322)
2.2 Tendenze di crescita della diagnostica delle malattie rare globali per regione
2.2.1 Dimensione del mercato della diagnostica delle malattie delle malattie rare per regione: 2018 vs 2024 vs 020322
2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.2.20 Diagnostica delle malattie Rare Diactions Diachastic per regione (2024-020322)
2.3 Dinamica del mercato della diagnostica delle malattie rare
2.3.3.1 Tendenze del settore della diagnostica delle malattie rare
2.3.2.2 Autisti del mercato della diagnostica della diagnostica delle malattie rare
2.3.3 Diagnostica delle malattie rare Rare Sfide
3.1.1 Global Rare Disease Diagnostics Revenue by Players (2018-2024)
3.1.2 Global Rare Disease Diagnostics Revenue Market Share by Players (2018-2024)
3.2 Global Rare Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Rare Disease Diagnostics, Ranking by Revenue, 2021 VS 2024 VS 2024
3.4 Global Rare Disease Diagnostics Market Concentration Ratio
3.4.1 Global Rare Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Disease Diagnostics Revenue in 2024
3.5 Global Key Players of Rare Disease Diagnostics Head office and Area Served
3.6 Global Key Players of Rare Disease Diagnostics, Product and Application
3.7 Global Giochi chiave della diagnostica delle malattie rare, data di inserire in questo settore
3.8 fusioni e acquisizioni, piani di espansione
4 Diagnostica delle malattie rare Dati di rottura per tipo
4.1 Global Rare Diagnostica Rare Diagnostica Dimensione del mercato storico per tipo (BR /> 5 RARE DEAMOSTS DATTICA by Application
5.1 Global Rare Disease Diagnostics Historic Market Size by Application (2018-2024)
5.2 Global Rare Disease Diagnostics Forecasted Market Size by Application (2024-020322)
6 North America
6.1 North America Rare Disease Diagnostics Market Size (2018-020322)
6.2 North America Rare Disease Diagnostics Market Size by Type
6.2.1 North Dimensione del mercato della diagnostica delle malattie rare dell'America per tipo (2018-2024)
6.2.2 Nord America Rare Diagnostica Dimensione del mercato per tipo (2024-020322)
6.2.3 Nord America Rare Diagnostica Nuota di mercato del North America Diagnostica per malattia North America. (2018-2024)
6.3.2 Nord America Rare Diagnostica Rare Diagnostica per applicazione (2024-020322)
6.3.3 Nord America Rare Diagnostica Diagnostica di mercato per applicazione (2018-020322)
6.4.4 Nord America Rare Diagnostica Diagnostica del mercato del paese
6.4.1 North America Rare Diagnostics Dimensioni del Paese: Paese per Paese: 2018 Vs: 2018 VS 2018 per Paese: 2018 VS 2018 per Paese: 2018 VS 2018 per Paese: 2018 VS 2018 per Paese: 2018 VS 2018 VS per Paese: 2018 VS per paese. 020322
6.4.2 North America Rare Disease Diagnostics Market Size by Country (2018-2024)
6.4.3 North America Rare Disease Diagnostics Market Size by Country (2024-020322)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Rare Disease Diagnostics Market Size (2018-020322)
7.2 Europe Rare Disease Diagnostics Market Size by Type
7.2.1 Europe Rare Disease Diagnostics Market Size by Type (2018-2024)
7.2.2 Europe Rare Disease Diagnostics Market Size by Type (2024-020322)
7.2.3 Europe Rare Disease Diagnostics Market Share by Type (2018-020322)
7.3 Europe Rare Disease Diagnostics Market Size by Application
7.3.1 Europa Dimensione del mercato della diagnostica delle malattie rare per applicazione (2018-2024)
7.3.2 Europa Dimensione del mercato della diagnostica delle malattie rare per applicazione (2024-020322)
7.3.3 Europa Rare Malattia Rare Diagnostica quota di mercato del mercato Rare. Vs 020322
7.4.2 Europa Dimensioni del mercato della diagnostica delle malattie rare per paese (2018-2024)
7.4.3 Europa Dimensioni del mercato della diagnostica delle malattie rare per paese (2024-020322)
7.4.3 Germania
7.4.4 Francia
7.4.5 />7.4.8 Nordic Countries
8 China
8.1 China Rare Disease Diagnostics Market Size (2018-020322)
8.2 China Rare Disease Diagnostics Market Size by Type
8.2.1 China Rare Disease Diagnostics Market Size by Type (2018-2024)
8.2.2 China Rare Disease Diagnostics Market Size by Type (2024-020322)
8.2.3 China Rare Disease Diagnostics Market Share by Type (2018-020322)
8.3 China Rare Disease Diagnostics Market Size by Application
8.3.1 China Rare Disease Diagnostics Market Size by Application (2018-2024)
8.3.2 China Rare Disease Diagnostics Market Size by Application (2024-020322)
8.3.3 China Rare Disease Diagnostics Market Share by Application (2018-020322)
9 Asia (excluding China)
9.1 Asia Rare Disease Diagnostics Market Size (2018-020322)
9.2 Asia Rare Disease Diagnostics Market Size by Type
9.2.1 Asia Rare Disease Diagnostics Market Size by Type (2018-2024)
9.2.2 Asia Rare Disease Diagnostics Market Size by Type (2024-020322)
9.2.3 Asia Rare Disease Diagnostics Market Share by Type (2018-020322)
9.3 Asia Rare Disease Diagnostics Market Size by Application
9.3.1 Asia Rare Disease Diagnostics Market Size by Application (2018-2024)
9.3.2 Asia Rare Disease Diagnostics Market Size by Application (2024-020322)
9.3.3 Asia Rare Malattia Diagnostica Diagnostica quota per applicazione (2018-020322)
9.4 Asia Rare Diagnostica Dimensione del mercato per regione
9.4.1 Asia Rare Diagnostica Diagnostica Dimensione del mercato per regione: 2018 vs 2024 vs 020322
.4.4.2.2 ASIA Rare Diagnostica Diagnostica Dimensione del mercato per regione (2018-20)
9.4.4 Giappone
9.4.5 Corea del Sud
9.4.6 China Taiwan
9.4.7 Sud-est asiatico
9.4.8 India
9.9.9 Australia
10 Medio Oriente, Africa e America Latina
10.110.1 Africa e Africa e lattina per le malattie delle malattie latine (2018-020) />10.2 Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Type (2024-020322)
10.2.3 Middle East, Africa, and Latin America Rare Disease Diagnostics Market Share Per tipo (2018-020322)
10.3 Medio Oriente, Africa e America Latina Dimensione del mercato della diagnostica delle malattie rare per applicazione
10.3.1 Medio Oriente, Africa e America Latina Rare Diagnostica Dimensione del mercato del mercato per applicazione (2018-2024)
10.3.3.3.3.2.2 Medio Oriente dell'Africa in America Latin Est, Africa e America Latina Rare Diagnostica della diagnostica Diagnostica per applicazione (2018-020322)
10.4 Medio Oriente, Africa e America Latina Dimensioni del mercato delle malattie rare per paesi
10.4.1 Medio Oriente, Africa e America Latina Rare Diagnostica Mercato delle malattie rare da paese da paese Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Rare Disease Diagnostics Market Size by Country (2024-020322)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Retrophin
11.1.1 Retrophin Company Details
11.1.2 Retrophin Business Overview
11.1.3 Retrophin Rare Disease Diagnostics Introduction
11.1.4 Retrophin Revenue in Rare Disease Diagnostics Business (2018-2024)
11.1.5 Retrophin Recent Developments
11.2 3billion
11.2.1 3billion Company Details
11.2.2 3billion Business Overview
11.2.3 3billion Rare Disease Diagnostics Introduction
11.2.4 3billion Revenue in Rare Disease Diagnostics Business (2018-2024)
11.2.5 3billion Recent Developments
11.3 23andMe
11.3.1 23andMe Company Details
11.3.2 23andMe Business Overview
11.3.3 23andMe Rare Disease Diagnostics Introduction
11.3.4 23andMe Revenue in Rare Disease Diagnostics Business (2018-2024)
11.3.5 23andMe Recent Developments
11.4 QIAGEN
11.4.1 QIAGEN Company Details
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Rare Disease Diagnostics Introduction
11.4.4 QIAGEN Revenue in Rare Disease Diagnostics Business (2018-2024)
11.4.5 QIAGEN Recent Developments
11.5 Illumina
11.5.1 Illumina Company Details
11.5.2 Illumina Business Overview
11.5.3 Illumina Rare Disease Diagnostica Introduzione
11.5.4 ILLUMINA RAGGIUNMI IN BUSINESS Diagnostica delle malattie rare (2018-2024)
11.5.5 ILLUMINA Sviluppi recenti
11.6 Perkinelmer
11.6.1 DEGALI DI PERKINELMER
111.6.2 PERKINELMER BUSINESS POVERVIEW
1111111111111111111.6.3 />11.6.4 PerkinElmer Revenue in Rare Disease Diagnostics Business (2018-2024)
11.6.5 PerkinElmer Recent Developments
11.7 Strand Life Sciences
11.7.1 Strand Life Sciences Company Details
11.7.2 Strand Life Sciences Business Overview
11.7.3 Strand Life Sciences Rare Disease Diagnostics Introduction
11.7.4 Strand Life Sciences Revenue in Rare Disease Diagnostics Business (2018-2024)
11.7.5 Strand Life Sciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Dettagli dell'autore
